Literature DB >> 10421044

Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii.

J Gómez1, E Simarro, V Baños, L Requena, J Ruiz, F García, M Canteras, M Valdés.   

Abstract

In this prospective study, the risk factors associated with nosocomial sepsis Caused by Acinetobacter baumannii or Pseudomonas aeruginosa were compared. Prior use of broad-spectrum antibiotics, urinary tract catheter, prior surgery, and mechanical ventilation were significantly associated with nosocomial sepsis caused by Acinetobacter baumannii. The mean prognostic factors significantly associated with mortality were known focus of infection, multiresistant Acinetobacter baumannii, and inappropriate antibiotic treatment. Adequate knowledge of these findings is important to ensure appropriate management of patients and rational use of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421044     DOI: 10.1007/pl00015019

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.

Authors:  T C Chang; A H Huang
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 2.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

3.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

Review 4.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

5.  Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong.

Authors:  E T Houang; Y W Chu; C M Leung; K Y Chu; J Berlau; K C Ng; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.

Authors:  José Garnacho-Montero; C Ortiz-Leyba; Esteban Fernández-Hinojosa; Teresa Aldabó-Pallás; Aurelio Cayuela; Juan A Marquez-Vácaro; Andrés Garcia-Curiel; F J Jiménez-Jiménez
Journal:  Intensive Care Med       Date:  2005-03-23       Impact factor: 17.440

7.  Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes.

Authors:  Kristine M Hujer; Nashaat S Hamza; Andrea M Hujer; Federico Perez; Marion S Helfand; Christopher R Bethel; Jodi M Thomson; Vernon E Anderson; Miriam Barlow; Louis B Rice; Fred C Tenover; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance.

Authors:  Stilianos Katsaragakis; Haridimos Markogiannakis; Konstantinos G Toutouzas; Panagiotis Drimousis; Andreas Larentzakis; Eleni-Maria Theodoraki; Dimitrios Theodorou
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

10.  Multidrug-resistant acinetobacter infection and their susceptibility patterns in a tertiary care hospital.

Authors:  Kalidas Rit; Rajdeep Saha
Journal:  Niger Med J       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.